Compounds > cholesteryl benzoate
Page last updated: 2024-12-09

cholesteryl benzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cholesteryl benzoate: RN given refers to (3beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2723613
SCHEMBL ID162524
MeSH IDM0094857

Synonyms (29)

Synonym
cholest-5-en-3-ol (3beta)-, 3-benzoate
unii-n09h13shlb
n09h13shlb ,
cholesteryl benzoate
cholesteryl benzoate, 98%
604-32-0
cholest-5-ene-3-beta-yl benzoate
cholest-5-en-3-ol (3beta)-, benzoate
einecs 210-064-3
cholesterol benzoate
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] benzoate
AKOS016015070
SCHEMBL162524
cholesteryl benzoate [who-dd]
cholesteryl benzoate [mart.]
5-cholesten-3-yl benzoate
3b-(benzoyloxy)cholest-5-ene
UVZUFUGNHDDLRQ-LLHZKFLPSA-N
cholest-5-en-3-yl benzoate #
Q-200844
chlortetracycline, antibiotic for culture media use only
J-640214
AS-59469
DTXSID10897509
Q1069880
(3s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl benzoate
AC8782
A868981
CS-W013828
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.33 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index55.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
cholesteryl butanoate
cholesteryl butanoate: RN given for (3beta)-isomer; structure in first source		2.0510
deoxycholic acid
Deoxycholic Acid: A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.. deoxycholic acid : A bile acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 12 respectively.		1.9710bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human blood serum metabolite
cholesteryl oleate
cholesteryl oleate: RN given refers to ((Z)-isomer). cholesteryl oleate : The (Z)-stereoisomer of cholesteryl octadec-9-enoate.		1.9610CE(18:1);
cholesteryl octadec-9-enoate		mouse metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Bone Cancer
[description not available]		01.9610
Cancer of Lung
[description not available]		01.9610
Bone Diseases
Diseases of BONES.		01.9610
Bone Neoplasms
Tumors or cancer located in bone tissue or specific BONES.		01.9610
Lung Neoplasms
Tumors or cancer of the LUNG.		01.9610
Osteomyelitis
INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.		01.9610